Tumor delineation using PET in head and neck cancers: Threshold contouring and lesion volumes

被引:88
作者
Ford, Eric C.
Kinahan, Paul E.
Hanlon, Lorraine
Alessio, Adam
Rajendran, Joseph
Schwartz, David L.
Phillips, Mark
机构
[1] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA
[2] Puget Sound Vet Adm, Seattle, WA 98195 USA
[3] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
[4] Univ Coll Dublin, Sch Phys, Dublin 2, Ireland
[5] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
关键词
PET; radiotherapy; target volume; thresholding; F-18-FDG; head and neck cancer;
D O I
10.1118/1.2361076
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Tumor boundary delineation using positron emission tomography (PET) is a promising tool for radiation therapy applications. In this study we quantify the uncertainties in tumor boundary delineation as a function of the reconstruction method, smoothing, and lesion size in head and neck cancer patients using FDG-PET images and evaluate the dosimetric impact on radiotherapy plans. FDG-PET images were acquired for eight patients with a GE Advance PET scanner. In addition, a 20 cm diameter cylindrical phantom with six FDG-filled spheres with volumes of 1.2 to 26.5 cm(3) was imaged. PET emission scans were reconstructed with the OSEM and FBP algorithms with different smoothing parameters. PET-based tumor regions were delineated using an automatic contouring function set at progressively higher threshold contour levels and the resulting volumes were calculated. CT-based tumor volumes were also contoured by a physician on coregistered PET/CT patient images. The intensity value of the threshold contour level that returns 100% of the actual volume, I-v100, was measured. We generated intensity-modulated radiotherapy (IMRT) plans for an example head and neck patient, treating 66 Gy to CT-based gross disease and 54 Gy to nodal regions at risk, followed by a boost to the FDG-PET-based tumor. The volumes of PET-based tumors are a sensitive function of threshold contour level for all patients and phantom datasets. A 5% change in threshold contour level can translate into a 200% increase in volume. Phantom data indicate that I-v100 can be set as a fraction, f, of the maximum measured uptake. Fractional threshold values in the cylindrical water phantom range from 0.23 to 0.51. Both the fractional threshold and the threshold-volume curve are dependent on lesion size, with lesions smaller than approximately 5 cm3 displaying a more pronounced sensitivity and larger fractional threshold values. The threshold-volume curves and fractional threshold values also depend on the reconstruction algorithm and smoothing filter with more smoothing requiring a higher fractional threshold contour level. The threshold contour level affects the tumor size, and therefore the ultimate boost dose that is achievable with IMRT. In an example head and neck IMRT plan, the D95 of the planning target volume decreased from 7770 to 7230 cGy for 42% vs 55% contour threshold levels. PET-based tumor volumes are strongly affected by the choice of threshold level. This can have a significant dosimetric impact. The appropriate threshold level depends on lesion size and image reconstruction parameters. These effects should be carefully considered when using PET contour and/or volume information for radiotherapy applications. (c) 2006 American Association of Physicists in Medicine.
引用
收藏
页码:4280 / 4288
页数:9
相关论文
共 52 条
[1]  
[Anonymous], 1999, J FORENSIC NEUROPSYC, DOI DOI 10.1300/J151V01N02_02
[2]   Investigation of a 3D gradient based method for volume segmentation in positron emission tomography for radiation treatment planning [J].
Aristophanous, M ;
Martel, M ;
Pelizzari, C ;
O'Brien-Penney, B .
MEDICAL PHYSICS, 2005, 32 (06) :1895-1895
[3]   Positron emission tomography partial volume correction: Estimation and algorithms [J].
Aston, JAD ;
Cunningham, VJ ;
Asselin, MC ;
Hammers, A ;
Evans, AC ;
Gunn, RN .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (08) :1019-1034
[4]   Automated localization of the prostate at the time of treatment using implanted radiopaque markers: Technical feasibility [J].
Balter, JM ;
Lam, KL ;
Sandler, HM ;
Littles, JF ;
Bree, RL ;
TenHaken, RK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (05) :1281-1286
[5]   Defining a radiotherapy target with positron emission tomography [J].
Black, QC ;
Grills, IS ;
Kestin, LL ;
Wong, CYO ;
Wong, JW ;
Martinez, AA ;
Yan, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (04) :1272-1282
[6]  
Boellaard R, 2004, J NUCL MED, V45, P1519
[7]  
Bohuslavizki KH, 2000, J NUCL MED, V41, P816
[8]   Modulated beam conformal therapy for head and neck tumors [J].
Boyer, AL ;
Geis, P ;
Grant, W ;
Carol, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (01) :227-236
[9]   Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer [J].
Bradley, J ;
Thorstad, WL ;
Mutic, S ;
Miller, TR ;
Dehdashti, F ;
Siegel, BA ;
Bosch, W ;
Bertrand, RJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01) :78-86
[10]   Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT:: The impact of 18FDG-hybrid PET fusion [J].
Caldwell, CB ;
Mah, K ;
Ung, YC ;
Danjoux, CE ;
Balogh, JM ;
Ganguli, SN ;
Ehrlich, LE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :923-931